| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/24/2002 | CN1345729A Novel polypeptide-protein 9.68 containing sodium-potassium ATP enzyme beta subunit character and polynucleotide for encoding said polypeptide |
| 04/23/2002 | US6376661 Human RNase H and compositions and uses thereof |
| 04/23/2002 | US6376660 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 04/23/2002 | US6376659 Recombinant expression vector |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376651 Amino acid sequences of a caf 1-related protein and to the use of these sequences in the diagnosis, treatment, and prevention of disorders associated with cell proliferation and inflammation. |
| 04/23/2002 | US6376459 Specific for gp39 on t cells was able to inhibit helper t-cell mediated b-cell activation by binding to a novel 39 kd protein receptor on helper t-cell membranes |
| 04/23/2002 | US6376217 Fusion protein comprising gelonin amino acid sequence having enzymatic activity and antibody, antigen-binding fragment, hormone, lymphokine or growth factor targeting sequence allowing internalization of fusion protein |
| 04/23/2002 | US6376215 JMY, a co-activator for p300/CBP, nucleic acid encoding JMY and uses thereof |
| 04/23/2002 | US6376207 Assay and reagents for quantifying hBNp |
| 04/23/2002 | US6376206 Specific antibodies to troponin T, their production and use in a reagent for the determination of myocardial necrosis |
| 04/23/2002 | US6376203 Isolated antibody immunologically reactive with mycoplasma fermentans glycoglycerophospholipid comprising glucose, fatty acid, phosphocholine and glycerol, being nonadsorptive to ion exchanger having diethylaminoethyl group, unstable to alkali |
| 04/23/2002 | US6376202 Methods and reagents for quantitation of HLA-DR expression on peripheral blood cells |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6376170 Ligand capture-directed selection of antibody |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | US6375949 Monoclonal antibody recognizing serum amyloid A |
| 04/23/2002 | CA2203765C Cathepsin o2 protease |
| 04/18/2002 | WO2002031464A2 Evaluating binding affinities by force stratification and force planning |
| 04/18/2002 | WO2002031198A2 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | WO2002031181A2 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/18/2002 | WO2002031154A1 Bzip type transcripiton factors regulating the expression of rice storage protein |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031144A2 Identification of cytotoxic activity from the ink of aplysia punctata |
| 04/18/2002 | WO2002031140A1 Cells producing antibody compositions |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody |
| 04/18/2002 | WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 04/18/2002 | WO2002030985A2 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 04/18/2002 | WO2002030984A1 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/18/2002 | WO2002030983A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 04/18/2002 | WO2002030982A2 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
| 04/18/2002 | WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | WO2002030980A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/18/2002 | WO2002030968A1 Novel mite allergens and uses therefor |
| 04/18/2002 | WO2002030967A2 Novel compounds |
| 04/18/2002 | WO2002030965A2 Nucleic acids encoding stichodactylidae chromoproteins |
| 04/18/2002 | WO2002030960A2 Polypeptide from haemophilus influenza |
| 04/18/2002 | WO2002030953A1 Method for modifying a protein structure |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030461A2 Methods for treating disorders of the female reproductive system |
| 04/18/2002 | WO2002030460A2 Therapeutic antibodies |
| 04/18/2002 | WO2002030459A1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28 |
| 04/18/2002 | WO2002030456A1 Targeting drug/gene carriers to irradiated tissue |
| 04/18/2002 | WO2002030421A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2002030321A2 Bird diagnostics and treatments |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2002007760A3 Therapeutic agent against aids comprising anti hiv goat antibody |
| 04/18/2002 | WO2002002642A3 Composition for pharmaceutical and cosmetic products |
| 04/18/2002 | WO2002000914A3 Bioengineered vehicles for targeted nucleic acid delivery |
| 04/18/2002 | WO2001085954A3 Serine-threonine kinase-3 |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001081579A8 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis |
| 04/18/2002 | WO2001081409A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/18/2002 | WO2001075448A3 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen |
| 04/18/2002 | WO2001075091A3 A method for in vitro molecular evolution of antibody function |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001064856A3 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 04/18/2002 | WO2001064752A3 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001058483A3 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2000073488A9 Plasmodium sp. chitinase |
| 04/18/2002 | WO2000069454A9 Suppression of endogenous igfbp-2 to inhibit cancer |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020045739 Acyl glucosaminyl inositol amidase family and methods of use |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045736 Anticarcinogenic agents for use in the treatment of cancer |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045579 Modulation of inflammation related to columnar epithelia |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045576 Novel neurotrophic factor |
| 04/18/2002 | US20020045273 Test methods and devices |
| 04/18/2002 | US20020045247 Expression vector for use in human and primate gene therapy |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045235 IKB kinase, subunits thereof, and methods of using same |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045202 Enzymatic polypeptide for use in diagnosis, prevention and treatment of inflammatory defects, cancer, diabetes |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
| 04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
| 04/18/2002 | US20020045165 Detecting target nucleotide sequences in sample; obtain sample, incubate sample with preferential nucleotides, detect bound sequences, classify sample |
| 04/18/2002 | US20020045164 Reagents and methods useful for detecting diseases of the lung |
| 04/18/2002 | US20020045161 Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell |
| 04/18/2002 | US20020044959 Biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell |
| 04/18/2002 | US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines |
| 04/18/2002 | US20020044945 Novel feline immunodeficiency virus nucleotide sequence |